International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy

Gene Gulati, Megan Hevelow, Melissa George, Eric Behling, Jamie Siegel

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Context.-The key question when managing patients on warfarin therapy who present with life-threatening bleeding is how to use the international normalized ratio (INR) to best direct corrective therapy. The corollary question for the clinical laboratory is at what level will the INR reflect a critical value that requires notifying the clinician. Objective.-To determine the levels of vitamin K-dependent factors over a range of INR values. Design.-Evaluation of the vitamin K-dependent coagulation factor levels on plasma remnants from patients in whom a prothrombin time and INR was ordered to monitor warfarin therapy. There were a total of 83 specimens evaluated with an INR range from 1.0 to 8.26. Results.-The mean activity levels of all 4 factors remained near or above 50% when the INR was less than 1.5. The average factor X level was 23% when the INR range was 1.6 to 2.5, but levels of factors II, VII, and IX did not drop below the hemostatic range until the INR was greater than 2.5. At an INR of 3.6 or more, the activity levels of all 4 factors were less than 30% in more than 90% of the specimens. Conclusion.-Levels of factors II, VII, IX, and X declined with increasing INR but not at the same rate and not to the same level at a given INR. However, most of the values were below the hemostatic value once the INR was 3.6 or more, the level that was also considered critical for physician notification.

Original languageEnglish (US)
Pages (from-to)490-494
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume135
Issue number4
StatePublished - Apr 1 2011

Fingerprint

Blood Coagulation Factors
International Normalized Ratio
Vitamin K
Therapeutics
Factor VII
Prothrombin
Hemostatics
Warfarin
Factor X
Factor IX
Prothrombin Time

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

@article{32489f6b303a43f6befbaf32a2cf25a1,
title = "International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy",
abstract = "Context.-The key question when managing patients on warfarin therapy who present with life-threatening bleeding is how to use the international normalized ratio (INR) to best direct corrective therapy. The corollary question for the clinical laboratory is at what level will the INR reflect a critical value that requires notifying the clinician. Objective.-To determine the levels of vitamin K-dependent factors over a range of INR values. Design.-Evaluation of the vitamin K-dependent coagulation factor levels on plasma remnants from patients in whom a prothrombin time and INR was ordered to monitor warfarin therapy. There were a total of 83 specimens evaluated with an INR range from 1.0 to 8.26. Results.-The mean activity levels of all 4 factors remained near or above 50{\%} when the INR was less than 1.5. The average factor X level was 23{\%} when the INR range was 1.6 to 2.5, but levels of factors II, VII, and IX did not drop below the hemostatic range until the INR was greater than 2.5. At an INR of 3.6 or more, the activity levels of all 4 factors were less than 30{\%} in more than 90{\%} of the specimens. Conclusion.-Levels of factors II, VII, IX, and X declined with increasing INR but not at the same rate and not to the same level at a given INR. However, most of the values were below the hemostatic value once the INR was 3.6 or more, the level that was also considered critical for physician notification.",
author = "Gene Gulati and Megan Hevelow and Melissa George and Eric Behling and Jamie Siegel",
year = "2011",
month = "4",
day = "1",
language = "English (US)",
volume = "135",
pages = "490--494",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy. / Gulati, Gene; Hevelow, Megan; George, Melissa; Behling, Eric; Siegel, Jamie.

In: Archives of Pathology and Laboratory Medicine, Vol. 135, No. 4, 01.04.2011, p. 490-494.

Research output: Contribution to journalArticle

TY - JOUR

T1 - International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy

AU - Gulati, Gene

AU - Hevelow, Megan

AU - George, Melissa

AU - Behling, Eric

AU - Siegel, Jamie

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Context.-The key question when managing patients on warfarin therapy who present with life-threatening bleeding is how to use the international normalized ratio (INR) to best direct corrective therapy. The corollary question for the clinical laboratory is at what level will the INR reflect a critical value that requires notifying the clinician. Objective.-To determine the levels of vitamin K-dependent factors over a range of INR values. Design.-Evaluation of the vitamin K-dependent coagulation factor levels on plasma remnants from patients in whom a prothrombin time and INR was ordered to monitor warfarin therapy. There were a total of 83 specimens evaluated with an INR range from 1.0 to 8.26. Results.-The mean activity levels of all 4 factors remained near or above 50% when the INR was less than 1.5. The average factor X level was 23% when the INR range was 1.6 to 2.5, but levels of factors II, VII, and IX did not drop below the hemostatic range until the INR was greater than 2.5. At an INR of 3.6 or more, the activity levels of all 4 factors were less than 30% in more than 90% of the specimens. Conclusion.-Levels of factors II, VII, IX, and X declined with increasing INR but not at the same rate and not to the same level at a given INR. However, most of the values were below the hemostatic value once the INR was 3.6 or more, the level that was also considered critical for physician notification.

AB - Context.-The key question when managing patients on warfarin therapy who present with life-threatening bleeding is how to use the international normalized ratio (INR) to best direct corrective therapy. The corollary question for the clinical laboratory is at what level will the INR reflect a critical value that requires notifying the clinician. Objective.-To determine the levels of vitamin K-dependent factors over a range of INR values. Design.-Evaluation of the vitamin K-dependent coagulation factor levels on plasma remnants from patients in whom a prothrombin time and INR was ordered to monitor warfarin therapy. There were a total of 83 specimens evaluated with an INR range from 1.0 to 8.26. Results.-The mean activity levels of all 4 factors remained near or above 50% when the INR was less than 1.5. The average factor X level was 23% when the INR range was 1.6 to 2.5, but levels of factors II, VII, and IX did not drop below the hemostatic range until the INR was greater than 2.5. At an INR of 3.6 or more, the activity levels of all 4 factors were less than 30% in more than 90% of the specimens. Conclusion.-Levels of factors II, VII, IX, and X declined with increasing INR but not at the same rate and not to the same level at a given INR. However, most of the values were below the hemostatic value once the INR was 3.6 or more, the level that was also considered critical for physician notification.

UR - http://www.scopus.com/inward/record.url?scp=79955084921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955084921&partnerID=8YFLogxK

M3 - Article

C2 - 21466367

AN - SCOPUS:79955084921

VL - 135

SP - 490

EP - 494

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -